Yuvezzi (brimonidine tartrate, carbachol)

New dosage form

Region: 🇺🇸 US
Active substance: brimonidine tartrate, carbachol
Company: Visus
Status: Approved
FDA approval: Wed 28 Jan 2026
Designations: New dosage form
Application: NDA220142
Official record: www.accessdata.fda.gov

Regulatory milestones

Wed 28 Jan 2026🇺🇸 FDA approval

FDA approves Yuvezzi (brimonidine tartrate, carbachol): new dosage form

Visus; NDA220142; New dosage form; solution/drops · source

Same substance in other markets

🇪🇺 Simbrinza Authorised · Novartis Europharm Limited

Follow Yuvezzi

Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.